Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04438824 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

Name: Palbociclib and INCMGA00012 in People With Advanced Liposarcoma — clinical trial record (NCT04438824)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 2

SponsorMemorial Sloan Kettering Cancer Center

Started2020-06-17

View on ClinicalTrials.gov ↗

The researchers are doing this study to find out whether combining the study drugs palbociclib and INCMGA00012 is an effective and safe treatment for advanced liposarcoma. "Funding Source - FDA OOPD"

Amendment history 2 changes detected by DataLookout

2026-09-15

Primary completion pushed: 2026-06 → 2027-06

2026-09-15

Completion pushed: 2026-06 → 2027-06

Trial Details

NCT Number	NCT04438824
Lead Sponsor	Memorial Sloan Kettering Cancer Center Collaborators: Incyte Corporation
Conditions	Well-differentiated/Dedifferentiated Liposarcoma
Enrollment	42 participants
Start Date	2020-06-17
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-09-14